Bring your questions to Lung Cancer OncTalk 2026. 💙
Join Dr. Alissa Cooper and leading oncologists for patient-centered presentations, expert discussions, and live Q&A.
📅 December 8 & 10
⏰ 7:30–8:45 PM ET
Attend either one or both virtual sessions!
Register: give.cancergrace.org/event/2026-lun…
Join Dr. Alissa Cooper and leading oncologists for patient-centered presentations, expert discussions, and live Q&A.
📅 December 8 & 10
⏰ 7:30–8:45 PM ET
Attend either one or both virtual sessions!
Register: give.cancergrace.org/event/2026-lun…
0
2
2
79
Meet our Lung Cancer OncTalk 2026 faculty! Join Dr. Alissa Cooper and fellow experts to explore lung cancer care and ask questions live.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #GRACE #NSCLC #SCLC
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #GRACE #NSCLC #SCLC
0
2
2
125
What’s new in lung cancer treatment? Join @LauraAlderMD at Lung Cancer OncTalk 2026 to explore ADCs, bispecific antibodies, and emerging therapies.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #NSCLC #ADCsBispecifics
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #NSCLC #ADCsBispecifics
0
4
2
263
What guides the first lung cancer treatment? Join Dr. @JessieStuart316 at Lung Cancer OncTalk 2026 to explore initial treatment options for NSCLC and SCLC.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #GRACE #NSCLC #SCLC
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #GRACE #NSCLC #SCLC
0
2
2
88
How does radiation fit into lung cancer care? Join Dr. Tafadzwa Chaunzwa at Lung Cancer OncTalk 2026 to learn about radiation and coordinated care.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer
1
1
1
72
An early-stage lung cancer diagnosis: What comes next?
Join Dr. Sarah Waliany at Lung Cancer OncTalk 2026 to learn about key testing and treatment options.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer
Join Dr. Sarah Waliany at Lung Cancer OncTalk 2026 to learn about key testing and treatment options.
📅 Dec. 8 & 10 | Free & virtual
Register: give.cancergrace.org/event/2026-lun…
#LungCancer
0
0
3
78
Meet Lung Cancer OncTalk 2026 chair Dr. Alissa Cooper! Join two evenings of lung cancer education and live Q&A.
📅 Dec. 8 & 10
⏰ 7:30–8:45 PM ET
💻 Attend one or both virtual sessions!
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #CancerGRACE
📅 Dec. 8 & 10
⏰ 7:30–8:45 PM ET
💻 Attend one or both virtual sessions!
Register: give.cancergrace.org/event/2026-lun…
#LungCancer #CancerGRACE
0
4
5
259
Join Lung Cancer OncTalk 2026, led by Dr. Alissa Cooper! Hear about current and emerging treatments and ask experts your questions live.
📅 Session 1: Tuesday, December 8, 2026
📅 Session 2: Thursday, December 10, 2026
⏰ Both sessions: 4:30–5:45 PM PT | 7:30–8:45 PM ET
Attend Register: give.cancergrace.org/event/2026-lun…
#LungCancer #LiveWebinar
📅 Session 1: Tuesday, December 8, 2026
📅 Session 2: Thursday, December 10, 2026
⏰ Both sessions: 4:30–5:45 PM PT | 7:30–8:45 PM ET
Attend Register: give.cancergrace.org/event/2026-lun…
#LungCancer #LiveWebinar
0
0
3
61
What is MRD, and what can it tell you about your blood cancer treatment? 🔎
Our patient-friendly article explains measurable residual disease (MRD), how doctors test for it, and what MRD-positive and MRD-negative results may mean.
Explore the basics and find helpful questions team.
📖 Read the article: cancergrace.org/post/what-meas…
#BloodCancer #MRD #PatientEducation #CancerGRACE
Our patient-friendly article explains measurable residual disease (MRD), how doctors test for it, and what MRD-positive and MRD-negative results may mean.
Explore the basics and find helpful questions team.
📖 Read the article: cancergrace.org/post/what-meas…
#BloodCancer #MRD #PatientEducation #CancerGRACE
0
0
2
93
Does every lung nodule mean lung cancer—and when does it need surgery?
Following Pope Leo XIV’s lung cancer diagnosis, learn when doctors monitor a lung nodule, recommend a biopsy, or consider surgery.
We explain CT screening, nodule size and growth, and follow-up guidelines.
Follow Larry, a fictional 68-year-old patient, inside illustrated lung tissue, an embedded nodule, and its cells. Learn the difference between screening and nodule follow-up, why biopsy is not always the first step, and which changes can prompt specialist evaluation. The incidental-nodule size guide applies to a single solid nodule in adults 35 or older, outside screening, without known cancer or weakened immunity. Multiple nodules and ground-glass/part-solid nodules follow different pathways. U.S. screening recommendations differ: USPSTF includes a 15-year quitting cutoff; ACS does not.
EPISODE PAGE & LEARNING RESOURCES
youtu.be/9vwuA_EbCxk?si…
Following Pope Leo XIV’s lung cancer diagnosis, learn when doctors monitor a lung nodule, recommend a biopsy, or consider surgery.
We explain CT screening, nodule size and growth, and follow-up guidelines.
Follow Larry, a fictional 68-year-old patient, inside illustrated lung tissue, an embedded nodule, and its cells. Learn the difference between screening and nodule follow-up, why biopsy is not always the first step, and which changes can prompt specialist evaluation. The incidental-nodule size guide applies to a single solid nodule in adults 35 or older, outside screening, without known cancer or weakened immunity. Multiple nodules and ground-glass/part-solid nodules follow different pathways. U.S. screening recommendations differ: USPSTF includes a 15-year quitting cutoff; ACS does not.
EPISODE PAGE & LEARNING RESOURCES
youtu.be/9vwuA_EbCxk?si…
0
0
2
160
💙 Thank you for joining Blood Cancers OncTalk 2026!
To every patient, caregiver, and community member who joined us: thank you for your time, thoughtful questions, and participation.
A heartfelt thank-you to our chair, Dr. Yumeng “Julia” Zhang, and our speakers, Dr. Blue, Dr. Supreet Kaur, and Dr. Shivani Handa, for sharing their expertise and making complex topics more accessible to patients and families.
We’re also deeply grateful to our sponsors—Takeda Oncology, Lilly Oncology, Bristol Myers Squibb, and Janssen—for helping make this free educational event possible.
Together, we’re helping more people access trusted cancer education. Thank you for being part of the GRACE community! 💙
#BloodCancer #CancerEducation #GRACE #OncTalk
To every patient, caregiver, and community member who joined us: thank you for your time, thoughtful questions, and participation.
A heartfelt thank-you to our chair, Dr. Yumeng “Julia” Zhang, and our speakers, Dr. Blue, Dr. Supreet Kaur, and Dr. Shivani Handa, for sharing their expertise and making complex topics more accessible to patients and families.
We’re also deeply grateful to our sponsors—Takeda Oncology, Lilly Oncology, Bristol Myers Squibb, and Janssen—for helping make this free educational event possible.
Together, we’re helping more people access trusted cancer education. Thank you for being part of the GRACE community! 💙
#BloodCancer #CancerEducation #GRACE #OncTalk
0
0
0
99
🔴 Another audience question in our live Q&A!
In a patient in their #30s#30sw do doctors distinguish clonal hematopoiesis of indeterminate potential (CHIP) from polycythemia vera (PV) when there is a JAK2 mutation, persistently high platelets, elevated red blood counts below PV diaga lower-end erythropoietin (EPO) level?
Our panel is discussing this diagnostic question at Blood Cancers OncTalk 2026.
💬 Join us now to hear more! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
In a patient in their #30s#30sw do doctors distinguish clonal hematopoiesis of indeterminate potential (CHIP) from polycythemia vera (PV) when there is a JAK2 mutation, persistently high platelets, elevated red blood counts below PV diaga lower-end erythropoietin (EPO) level?
Our panel is discussing this diagnostic question at Blood Cancers OncTalk 2026.
💬 Join us now to hear more! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
0
0
3
145
🔴 Our second panel’s live Q&A is underway at Blood Cancers OncTalk 2026!
Our experts are answering your questions about MPNs:
▪️ What determines someone’s risk of complications like blood clots, and how does that guide treatment?
▪️ What changes in blood counts, symptoms, or testhat an MPN is progressing?
💬 Join us now to hear the discussion and bring your questions! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
Our experts are answering your questions about MPNs:
▪️ What determines someone’s risk of complications like blood clots, and how does that guide treatment?
▪️ What changes in blood counts, symptoms, or testhat an MPN is progressing?
💬 Join us now to hear the discussion and bring your questions! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
0
0
0
61
🔴 How do we treat #myelofibrosis?
Dr. Shivani Handa is discussing treatment options for myelofibrosis as part of her presentation on MPNs at Blood Cancers OncTalk 2026.
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#Myelofibrosis #MPNs #BloodCancer #GRACE #OncTalk
Dr. Shivani Handa is discussing treatment options for myelofibrosis as part of her presentation on MPNs at Blood Cancers OncTalk 2026.
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#Myelofibrosis #MPNs #BloodCancer #GRACE #OncTalk
0
0
2
78
🔴 Happening now: Complications in MPNs, #Thrombosis
Dr. Shivani Handa is discussing blood clot risks associated with myeloproliferative neoplasms (MPNs) at Blood Cancers OncTalk 2026.
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
Dr. Shivani Handa is discussing blood clot risks associated with myeloproliferative neoplasms (MPNs) at Blood Cancers OncTalk 2026.
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
0
0
1
127
🔴 Taking the virtual stage: Dr. Shivani Handa!
Now presenting “Myeloproliferative Neoplasms (MPNs) in 2026” at Blood Cancers OncTalk.
Learn about MPN symptoms and blood clot risks, who may need treatment, available options, and newer treatment developments.
💬 Join us now to s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
Now presenting “Myeloproliferative Neoplasms (MPNs) in 2026” at Blood Cancers OncTalk.
Learn about MPN symptoms and blood clot risks, who may need treatment, available options, and newer treatment developments.
💬 Join us now to s free:
give.cancergrace.org/event/blood-ca…
#MPNs #BloodCancer #GRACE #OncTalk
0
0
2
74
🔴 Now presenting: Dr. Supreet Kaur!
How can your immune system help fight lymphoma? Dr. Kaur is discussing CAR T-cell therapy and bispecific antibodies for aggressive B-cell lymphoma at Blood Cancers OncTalk 2026.
Together, we’ll explore:
▪️ Who these treatments are for
▪️ during, and after treatment
▪️ How side effects are monitored and managed
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#Lymphoma #CARTCellTherapy #BloodCancer #GRACE #OncTalk
How can your immune system help fight lymphoma? Dr. Kaur is discussing CAR T-cell therapy and bispecific antibodies for aggressive B-cell lymphoma at Blood Cancers OncTalk 2026.
Together, we’ll explore:
▪️ Who these treatments are for
▪️ during, and after treatment
▪️ How side effects are monitored and managed
💬 Join us now to hear more about it! It’s free:
give.cancergrace.org/event/blood-ca…
#Lymphoma #CARTCellTherapy #BloodCancer #GRACE #OncTalk
0
2
0
86
🔴 Our live Q&A is underway at Blood Cancers OncTalk 2026!
First up: a question about #lenalidomide’s safety and concerns about reports patients may have heard. Our experts are discussing how to understand treatment benefits and risks.
💬 Join us now to hear the discussion and brinfree:
give.cancergrace.org/event/blood-ca…
#BloodCancer #MultipleMyeloma #GRACE #OncTalk
First up: a question about #lenalidomide’s safety and concerns about reports patients may have heard. Our experts are discussing how to understand treatment benefits and risks.
💬 Join us now to hear the discussion and brinfree:
give.cancergrace.org/event/blood-ca…
#BloodCancer #MultipleMyeloma #GRACE #OncTalk
0
2
2
85